Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCYC for Cognitive Impairment After Robot-Assisted ICH Surgery
NCT06673602Phase 4Recruiting
- Sponsor
- Qinhuangdao Hospital of Traditional Chinese Medicine
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fufang congrong yizhi in cognitive impairment, sponsored by Qinhuangdao Hospital of Traditional Chinese Medicine. Started Nov 2024; status: recruiting.
02
Drugs
fufang congrong yizhi
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT06673602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06673602.